Speech-Language Pathologists in Maple Park, IL Accepting Medicare

4 Speech-Language Pathologists found. Showing 1 - 4

Blazing Prairie Stars Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 47w635 Beith Rd, Maple Park, IL 60151 Phone: 630-365-5550    Fax: 630-365-9550

Tlc Speech Services Pc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 309 W Burlington Dr, Maple Park, IL 60151 Phone: 630-853-6012    Fax: 815-827-3792

Cheryl Bowen Cutsinger, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 325 W Elian Ct, Maple Park, IL 60151 Phone: 815-501-3284

Terri Lynn Robinson, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 309 W Burlington Dr, Maple Park, IL 60151 Phone: 630-853-6012    Fax: 815-827-3792

News Archive

Cell Therapeutics reports cardiac safety results from phase II trial of pixantrone in CHOP-R regimen

Cell Therapeutics, Inc. reported today preliminary cardiac safety results from a North American randomized phase II trial which substituted pixantrone for doxorubicin in the standard CHOP-R regimen. Called PIX203, the randomized trial compared CPOP-R directly to CHOP-R in the 1st line treatment of high risk patients with diffuse large B cell non-Hodgkin's lymphoma (DLBCL, NHL).

New book presents latest research on neuroendocrine physiology

In this volume an international group of basic and clinical investigators presents their latest research on neuroendocrine physiology, advances in the control of the onset of puberty and its disorders, and basic and clinical aspects of the GH/IGF-1 and hypothalamic-pituitary-adrenal axes. An entire section is dedicated to pituitary tumors, including genetics and neuroimaging, and another covers the neuroendocrine control of substrate metabolism, including hypothalamic obesity and anorexia.

Dravet Syndrome Foundation awards OPKO Health grant to develop potential therapeutic agents

OPKO Health, Inc. announced today that it has been awarded a grant from the Dravet Syndrome Foundation to support the Company's efforts to develop potential therapeutic agents to treat a rare genetic disorder, Dravet Syndrome, also called severe myoclonic epilepsy of infancy, a severe form of epilepsy that usually appears during the first year of life.

Medica Research Institute launched for applying innovation to healthcare delivery

Medica today announced the launch of the Medica Research Institute as a non-profit company that will serve as the research arm within the broader organization. Built on the principals of systematic investigation, some potential areas of study include health services research, comparative effectiveness research and clinical trial studies.

Virginia bill may prompt state-federal fight over insurance mandate

A bill in the Virginia state legislature could upend a critical provision of the Democrats' health overhaul and open the door for a fresh battle over the federal government's power over states, The Boston Globe reports.

Read more Medical News

› Verified 3 days ago